Cargando…

The Possible Role of Cancer Stem Cells in the Resistance to Kinase Inhibitors of Advanced Thyroid Cancer

Target therapy with various kinase inhibitors (KIs) has been extended to patients with advanced thyroid cancer, but only a subset of these compounds has displayed efficacy in clinical use. However, after an initial response to KIs, dramatic disease progression occurs in most cases. With the discover...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gianì, Fiorenza, Vella, Veronica, Tumino, Dario, Malandrino, Pasqualino, Frasca, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465706/ https://www.ncbi.nlm.nih.gov/pubmed/32796774 http://dx.doi.org/10.3390/cancers12082249

Ejemplares similares

Levothyroxine therapy, calculated deiodinases activity and basal metabolic rate in obese or nonobese patients after total thyroidectomy for differentiated thyroid cancer, results of a retrospective observational study
por: Le Moli, Rosario, et al.
Publicado: (2023)

Heavy Metals in the Environment and Thyroid Cancer
por: Gianì, Fiorenza, et al.
Publicado: (2021)

Updates on the Management of Advanced, Metastatic, and Radioiodine Refractory Differentiated Thyroid Cancer
por: Tumino, Dario, et al.
Publicado: (2017)

Different FT3/TSH correlation in acquired and congenital hypothyroid patients reveals a different hypothalamic set‐point
por: Russo, Marco, et al.
Publicado: (2022)

Increased Thyroid Cancer Incidence in Volcanic Areas: A Role of Increased Heavy Metals in the Environment?
por: Malandrino, Pasqualino, et al.
Publicado: (2020)

Inflammasome activation as a link between obesity and thyroid disorders: Implications for an integrated clinical management
por: Le Moli, Rosario, et al.
Publicado: (2022)

Anaplastic Thyroid Cancer in Sicily: The Role of Environmental Characteristics
por: Tavarelli, Martina, et al.
Publicado: (2017)

The Role of the Kinase Inhibitors in Thyroid Cancers
por: Cuomo, Francesca, et al.
Publicado: (2022)

Effect of gluten-free diet on autoimmune thyroiditis progression in patients with no symptoms or histology of celiac disease: a meta-analysis
por: Piticchio, Tommaso, et al.
Publicado: (2023)

Lenvatinib and other tyrosine kinase inhibitors for the treatment of radioiodine refractory, advanced, and progressive thyroid cancer
por: Lorusso, Loredana, et al.
Publicado: (2016)

MON-537 Primary Adrenal Insufficiency During Tyrosine Kinase Inhibitors Treatment in Advanced Thyroid Cancer Patients
por: Valerio, Laura, et al.
Publicado: (2020)

Kinase inhibitors in thyroid cancers
por: Sukrithan, Vineeth, et al.
Publicado: (2023)

Corticosteroid Pulse Therapy for Graves' Ophthalmopathy Reduces the Relapse Rate of Graves' Hyperthyroidism
por: Le Moli, Rosario, et al.
Publicado: (2020)

Familial Non-Medullary Thyroid Cancer Represents an Independent Risk Factor for Increased Cancer Aggressiveness: A Retrospective Analysis of 74 Families
por: Tavarelli, Martina, et al.
Publicado: (2015)

Kinase inhibitors for advanced medullary thyroid carcinoma
por: Schlumberger, Martin, et al.
Publicado: (2012)

Descriptive Epidemiology of Human Thyroid Cancer: Experience From a Regional Registry and The “Volcanic Factor”
por: Malandrino, Pasqualino, et al.
Publicado: (2013)

Insulin Resistance: Any Role in the Changing Epidemiology of Thyroid Cancer?
por: Malaguarnera, Roberta, et al.
Publicado: (2017)

Effects of a Phosphoinositide-3-Kinase Inhibitor on Anaplastic Thyroid Cancer Stem Cells
por: Bozorg-Ghalati, Farzaneh, et al.
Publicado: (2017)

Adrenal insufficiency in thyroid cancer patients treated with tyrosine kinase inhibitors and detected by ACTH stimulation test
por: Valerio, L., et al.
Publicado: (2023)

Activation of the IGF Axis in Thyroid Cancer: Implications for Tumorigenesis and Treatment
por: Manzella, Livia, et al.
Publicado: (2019)

Kinase Inhibitors in the Treatment of Thyroid Cancer: Institutional Experience
por: Pešorda, Matea, et al.
Publicado: (2020)

RET kinase inhibitors for RET-altered thyroid cancers
por: Vodopivec, Danica M., et al.
Publicado: (2022)

Thyroidectomy as Treatment of Choice for Differentiated Thyroid Cancer
por: Giuffrida, Dario, et al.
Publicado: (2019)

Thyroid Stem Cells But Not Differentiated Thyrocytes Are Sensitive to Slightly Increased Concentrations of Heavy Metals
por: Gianì, Fiorenza, et al.
Publicado: (2021)

Antioxidant Defense Capacity Is Reduced in Thyroid Stem/Precursor Cells Compared to Differentiated Thyrocytes
por: Gianì, Fiorenza, et al.
Publicado: (2023)

Osteonecrosis of the jaw: a rare but possible side effect in thyroid cancer patients treated with tyrosine-kinase inhibitors and bisphosphonates
por: Lorusso, L., et al.
Publicado: (2021)

Recapitulating thyroid cancer histotypes through engineering embryonic stem cells
por: Veschi, Veronica, et al.
Publicado: (2023)

The Emerging Role of Insulin Receptor Isoforms in Thyroid Cancer: Clinical Implications and New Perspectives
por: Vella, Veronica, et al.
Publicado: (2018)

Cancer Stem Cells in Thyroid Tumors: From the Origin to Metastasis
por: Veschi, Veronica, et al.
Publicado: (2020)

Editorial: Clinical and Molecular Epidemiology of Thyroid Cancer of Follicular Origin
por: Malaguarnera, Roberta, et al.
Publicado: (2018)

Metabolic Alterations of Thyroid Cancer as Potential Therapeutic Targets
por: Ciavardelli, Domenico, et al.
Publicado: (2017)

Effect of Pre-Existent Sarcopenia on Oncological Outcome of Advanced Thyroid Cancer Patients Treated with Tyrosine Kinase Inhibitors
por: Dalmiglio, Cristina, et al.
Publicado: (2022)

New Treatment in Advanced Thyroid Cancer
por: Giuffrida, Dario, et al.
Publicado: (2012)

Worldwide Increasing Incidence of Thyroid Cancer: Update on Epidemiology and Risk Factors
por: Pellegriti, Gabriella, et al.
Publicado: (2013)

Challenges Associated with Tyrosine Kinase Inhibitor Therapy for Metastatic Thyroid Cancer
por: Cabanillas, Maria E., et al.
Publicado: (2011)

The Adverse Effect of Hypertension in the Treatment of Thyroid Cancer with Multi-Kinase Inhibitors
por: Ancker, Ole Vincent, et al.
Publicado: (2017)

Preclinical Evaluation of Novel Tyrosine-Kinase Inhibitors in Medullary Thyroid Cancer
por: Saronni, Davide, et al.
Publicado: (2022)

Target Therapy in Thyroid Cancer: Current Challenge in Clinical Use of Tyrosine Kinase Inhibitors and Management of Side Effects
por: Puliafito, Ivana, et al.
Publicado: (2022)

Thyroid Cancer and Circadian Clock Disruption
por: Malaguarnera, Roberta, et al.
Publicado: (2020)

Intake of Boron, Cadmium, and Molybdenum enhances rat thyroid cell transformation
por: Luca, Emilia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2nlku5sfddpnupqmes8bavav4s